<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(AMENDMENT NO. 2)
CORAM HEALTHCARE CORPORATION
----------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
-----------------------------
(Title of Class of Securities)
218103109
--------------
(CUSIP Number)
APRIL 9, 1999
-------------------------------------------------------
(Date of Event which Required Filing of this Statement)
CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE
IS FILED:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
<PAGE>
CUSIP NO. 218103109 PAGE 2 OF 18 PAGES
SCHEDULE 13G
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Foothill Capital Corporation
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 741,920(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
741,920(1) (See Items 2 and 4)
-------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 741,920(1)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11
1.48%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon conversion of $1,483,841 principal amount of
the Company's Series B Senior Subordinated Convertible Notes (the "Series B
Notes") at a conversion price of $2.00 per share of Common Stock, subject
to downward adjustment. The Series B Notes have a term of 10 years. The
conversion price was amended from $3.00 per share on April 9, 1999.
(2) Based on the number of shares outstanding as reported in the Company's
Annual Report on Form 10-K for the year ended December 31, 1999, and
assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
CUSIP NO. 218103109 PAGE 3 OF 18 PAGES
SCHEDULE 13G
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
The Foothill Group, Inc.
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
6
NUMBER OF 8,243,561(1) (See Items 2 and 4)
SHARES -------------------------------------------------------------
BENEFICIALLY SOLE DISPOSITIVE POWER
OWNED BY 7
EACH - 0 -
REPORTING -------------------------------------------------------------
PERSON SHARED DISPOSITIVE POWER
WITH 8
8,243,561(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
8,243,561(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 14.29%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon conversion of $16,487,123 principal amount
of the Company's Series B Notes at a conversion price of $2.00 per share of
Common Stock, subject to downward adjustment. The conversion price was
amended from $3.00 per share on April 9, 1999.
(2) Based on the number of shares outstanding as reported in the Company's
Annual Report on Form 10-K for the year ended December 31, 1999, and
assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
CUSIP NO. 218103109 PAGE 4 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Foothill Partners II, L.P.
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
6
NUMBER OF 7,501,641(1) (See Items 2 and 4)
SHARES -------------------------------------------------------------
BENEFICIALLY SOLE DISPOSITIVE POWER
OWNED BY 7
EACH - 0 -
REPORTING -------------------------------------------------------------
PERSON SHARED DISPOSITIVE POWER
WITH 8
7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.18%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon conversion of $15,003,282 principal amount
of the Company's Series B Notes at a conversion price of $2.00 per share of
Common Stock, subject to downward adjustment. The conversion price was
amended from $3.00 per share on April 9, 1999.
(2) Based on the number of shares outstanding as reported in the Company's
Annual Report on Form 10-K for the year ended December 31, 1999, and
assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
CUSIP NO. 218103109 PAGE 5 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
M. Edward Stearns
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,857,929(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.71%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) 7,501,641 shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment. The additional 356,288 shares are issuable upon exercise of
Common Stock Purchase Warrants at an exercise price of $0.01 per share of
Common Stock (the "Warrants").
(2) Assuming issuance of Common Stock upon (a) conversion of the Series B Notes
and (b) exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 6 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Karen S. Sandler
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,857,929(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.71%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) 7,501,641 shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment. The additional 356,288 shares are issuable upon exercise of
the Warrants at an exercise price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon (a) conversion of the Series B Notes
and (b) exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 7 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Dennis R. Ascher
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,857,929(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.71%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) 7,501,641 shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment. The additional 356,288 shares are issuable upon exercise of
the Warrants at an exercise price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon (a) conversion of the Series B Notes
and (b) exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 8 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Peter E. Schwab
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,501,641(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.18%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
CUSIP NO. 218103109 PAGE 9 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
David C. Hilton
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,501,641(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,501,641(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.18%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
<PAGE>
CUSIP NO. 218103109 PAGE 10 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Jeffrey T. Nikora
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
--------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,857,929(1) (See Items 2 and 4)
BENEFICIALLY --------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON --------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.71%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) 7,501,641 shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment. The additional 356,288 shares are issuable upon exercise of
the Warrants at an exercise price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon (a) conversion of the Series B Notes
and (b) exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 11 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
John F. Nickoll
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
California
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
NUMBER OF 6
SHARES 7,857,929(1) (See Items 2 and 4)
BENEFICIALLY -------------------------------------------------------------
OWNED BY SOLE DISPOSITIVE POWER
EACH 7
REPORTING - 0 -
PERSON -------------------------------------------------------------
WITH SHARED DISPOSITIVE POWER
8
7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 7,857,929(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 13.71%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) 7,501,641 shares are issuable upon conversion of the Series B Notes at a
conversion price of $2.00 per share of Common Stock, subject to downward
adjustment. The additional 356,288 shares are issuable upon exercise of
the Warrants at an exercise price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon (a) conversion of the Series B Notes
and (b) exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 12 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON*
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
Foothill Income Trust, L.P.
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
6
NUMBER OF 356,288(1)
SHARES -------------------------------------------------------------
BENEFICIALLY SOLE DISPOSITIVE POWER
OWNED BY 7
EACH - 0 -
REPORTING -------------------------------------------------------------
PERSON SHARED DISPOSITIVE POWER
WITH 8
356,288(1)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 356,288(1)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 0.72%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon exercise of the Warrants at an exercise
price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 13 OF 18 PAGES
SCHEDULE 13G
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
1
FIT GP, LLC
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
2 (b) / /
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- -------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- -------------------------------------------------------------------------------
SOLE VOTING POWER
5
- 0 -
-------------------------------------------------------------
SHARED VOTING POWER
6
NUMBER OF 356,288(1) (See Items 2 and 4)
SHARES -------------------------------------------------------------
BENEFICIALLY SOLE DISPOSITIVE POWER
OWNED BY 7
EACH - 0 -
REPORTING -------------------------------------------------------------
PERSON SHARED DISPOSITIVE POWER
WITH 8
356,288(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 356,288(1) (See Items 2 and 4)
- -------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
10
- -------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
11 0.72%(2)
- -------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 OO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
________________________
(1) These shares are issuable upon exercise of the Warrants at an exercise
price of $0.01 per share of Common Stock.
(2) Assuming issuance of Common Stock upon exercise of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 14 OF 18 PAGES
ITEM 1.
Coram Healthcare Corporation
1125 Seventeenth Street, Suite 1500
Denver, Colorado 80202
ITEM 2.
This Amendment No. 2 to the Schedule 13G originally filed on July 10,
1998 and amended August 25, 1998 is filed on behalf of The Foothill
Group, Inc., a Delaware Corporation ("Group"), Foothill Capital
Corporation, a California corporation ("Capital"), Foothill
Partners II, L.P., a Delaware limited partnership ("Partners"),
Foothill Income Trust, L.P., a Delaware limited partnership ("Foothill
Trust"), FIT GP, LLC, a Delaware limited liability company ("FIT") and
M. Edward Stearns, Karen S. Sandler, Dennis R. Ascher, Jeffrey
T. Nikora, and John F. Nickoll (collectively, the "Managing
Partners/Members") and Peter E. Schwab and David C. Hilton (the
"Managing Partners"). (Group, Capital, Partners, Foothill Trust, FIT,
the Managing Partners/Members and the Managing Partners are
collectively referred to as the "Filing Persons").
Group, the Managing Partners/Members and the Managing Partners are the
general partners of Partners. Capital is a wholly-owned subsidiary of
Group. FIT is the general partner of Foothill Trust and the Managing
Partners/Members are the managing members of FIT.
Under the definition of "beneficial owner" provided in Rule 13d-3 of
the Exchange Act, a person may be deemed to beneficially own the
shares of Common Stock of another entity if such person shares the
voting and dispositive power with respect to shares of Common Stock
held by such entity. Accordingly, (i) Group, the Managing
Partners/Members and the Managing Partners may be deemed to
beneficially own the shares of Common Stock held by Partners, as its
general partners, (ii) the Managing Partners/Members may be deemed to
beneficially own the shares of Common Stock held by Foothill Trust as
the managing members of the general partner of Foothill Trust, (iii)
FIT may be deemed to beneficially own the shares of Common Stock held
by Foothill Trust, as its general partner, and (iv) Group may be
deemed to beneficially own the shares held by Foothill Capital as its
sole shareholder.
The Filing Persons have a beneficial interest in all or part of
$16,487,123 principal amount of the Company's Series B Senior
Subordinated Convertible Notes which are convertible into the
Company's Common Stock at a conversion price of $2.00 per share. The
conversion price was amended from $3.00 per share on April 9, 1999.
In addition, certain Filing Persons own warrants that are exercisable
into shares of the Company's Common Stock.
(a) The Foothill Group, Inc.
Foothill Capital Corporation
Foothill Partners II, L.P.
Foothill Income Trust, L.P.
FIT GP, LLC
M. Edward Stearns
Karen S. Sandler
Dennis R. Ascher
Peter E. Schwab
David C. Hilton
Jeffrey T. Nikora
John F. Nickoll
(b) 11111 Santa Monica Boulevard, Suite 1500
Los Angeles, California 90025-3333
(c) United States
(d) Common Stock, $.001 par value
(e) 218103109
<PAGE>
CUSIP NO. 218103109 PAGE 15 OF 18 PAGES
ITEM 3.
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) / / Broker or dealer registered under Section 15 of the
Exchange Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) / / Investment company registered under Section 8 of the
Investment Company Act.
(e) / / An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the
Investment Company Act.
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box /X/
ITEM 4. OWNERSHIP
The ownership of the Filing Persons is as follows:
GROUP
A. Amount Beneficially owned: 8,243,561 (1)
B. Percent of class: 14.29%(2)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote or to direct to vote: 8,243,561(1)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
8,243,561(1)
EACH OF THE MANAGING PARTNERS/MEMBERS
A. Amount Beneficially owned: 7,857,929 (3)(4)
B. Percent of class: 13.71%(2)(5)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 7,857,929(3)(4)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
7,857,929(3)(4)
- -----------------------
(1) These shares are issuable upon conversion of the Company's Series B Notes
at a conversion price of $2.00 per share of Common Stock, subject to
downward adjustment.
(2) Assuming issuance of Common Stock upon conversion of the Series B Notes.
(3) Includes 356,288 shares issuable upon exercise of the Warrants at an
exercise price of $0.01 per share of Common Stock.
(4) Includes 7,857,929 shares issuable upon conversion of the Company's Series
B Notes at a conversion price of $2.00 per share of Common Stock, subject
to downward adjustment.
(5) Assuming issuance of Common Stock upon conversion of the Warrants.
<PAGE>
CUSIP NO. 218103109 PAGE 16 OF 18 PAGES
PARTNERS AND EACH OF THE MANAGING PARTNERS
A. Amount Beneficially owned: 7,501,641(1)
B. Percent of class: 13.18%(2)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 7,501,641(1)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
7,501,641(1)
CAPITAL
A. Amount Beneficially owned: 741,920(1)
B. Percent of class: 1.48%(2)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote a direct to vote: 741,920(1)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
741,920(1)
FOOTHILL TRUST AND FIT
A. Amount Beneficially owned: 356,288(3)
B. Percent of Class: 0.72%(5)
C. Number of shares as to which such person has:
1. sole power to vote or to direct the vote: -0-
2. shared power to vote or to direct the vote: 356,288(3)
3. sole power to vote or to direct to vote: -0-
4. shared power to dispose or to direct the disposition of:
356,288(3)
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities check the
following / /
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
<PAGE>
CUSIP NO. 218103109 PAGE 17 OF 18 PAGES
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are not held for the
purpose or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired in connection with or as a participant
in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: April 12, 1999
FOOTHILL CAPITAL CORPORATION
By: /s/ M.E. Stearns
--------------------------------------------
Name: M.E. Stearns
Title: Senior Vice President
THE FOOTHILL GROUP, INC.
By: /s/ M.E. Stearns
--------------------------------------------
Name: M.E. Stearns
Title: Senior Vice President
FOOTHILL PARTNERS II, L.P.,
a Delaware limited partnership
By: The Foothill Group, Inc.,
General Partner
By: /s/ M.E. Stearns
----------------------------------------
Name: M.E. Stearns
Title: Senior Vice President
FOOTHILL INCOME TRUST, L.P.,
a Delaware limited partnership
By: FIT GP, LLC
Its General Partner
By: /s/ M.E. Stearns
----------------------------------------
Name: M.E. Stearns
Title: Managing Member
<PAGE>
CUSIP NO. 218103109 PAGE 18 OF 18 PAGES
MANAGING PARTNERS/MEMBERS
/s/ M.E. Stearns
-------------------------------------------
M. E. Stearns
/s/ Karen S. Sandler
-------------------------------------------
Karen S. Sandler
/s/ Dennis R. Ascher
-------------------------------------------
Dennis R. Ascher
/s/ Jeffrey T. Nikora
-------------------------------------------
Jeffrey T. Nikora
/s/ John F. Nickoll
-------------------------------------------
John F. Nickoll
MANAGING PARTNERS
/s/ Peter E. Schwab
-------------------------------------------
Peter E. Schwab
/s/ David C. Hilton
-------------------------------------------
David C. Hilton
